Most Phesgo side effects are mild to moderate and peak during the first few treatment cycles, gradually improving as your body adjusts. How long they last depends on the specific side effect: digestive issues like diarrhea typically resolve within two to three weeks per episode, while the drugs themselves take several months to fully clear your system after your last dose.
Diarrhea: The Most Common Side Effect
Diarrhea is the side effect most people ask about, and it tends to hit hardest early in treatment. After your first cycle, diarrhea typically starts about seven days after the dose. In later cycles, the onset shifts slightly later, with a median of about 11 days after any given dose.
The median duration of the longest diarrhea episode in clinical trials was 18 days for patients receiving pertuzumab-based treatment (both active ingredients in Phesgo), compared to 8 days for those on placebo. Most episodes are mild to moderate and concentrated in the first few cycles. Many patients find that diarrhea becomes less frequent and less severe as treatment continues, though your care team can recommend management strategies if it persists.
Nausea, Fatigue, and Other Early Side Effects
Nausea, fatigue, and hair thinning follow a similar pattern to diarrhea: they tend to be worst in the opening cycles of treatment and ease over time. When Phesgo is given alongside chemotherapy (as it often is in early-stage or metastatic breast cancer), many of these symptoms overlap with chemotherapy side effects. Separating which drug is causing what can be difficult, but the combination effect means the first few months of treatment are generally the roughest stretch.
Injection site reactions, including redness, swelling, or mild pain where the shot was given, are specific to Phesgo’s subcutaneous delivery. These are usually short-lived, resolving within a few days of each dose.
How Long Phesgo Stays in Your Body
Phesgo contains two antibody drugs: pertuzumab (the active ingredient in Perjeta) and trastuzumab (the active ingredient in Herceptin). Pertuzumab has a half-life of about 24 days, and trastuzumab’s is about 22 days. A half-life is the time it takes for half of the drug to leave your system.
In practical terms, it takes roughly five half-lives for a drug to be considered fully cleared. That means pertuzumab lingers for about four months and trastuzumab for about three and a half months after your final injection. Side effects tied directly to the drug’s presence in your body, like fatigue or digestive issues, can potentially continue during this washout period, though they usually fade well before the drug is completely gone.
Heart Function: A Longer Timeline
Both active ingredients in Phesgo can affect how well your heart pumps, measured by a number called the left ventricular ejection fraction (LVEF). This is why your care team monitors your heart function every three months during treatment. After you finish treatment, heart monitoring typically continues every six months for at least two years.
The reassuring news is that heart changes from these drugs are generally reversible, unlike the permanent damage that some older chemotherapy agents can cause. Most patients who experience a dip in heart function recover enough to continue or resume treatment. However, recovery isn’t always complete. Research suggests that in roughly half of affected patients, the recovery is only partial, and in 12 to 29 percent of cases, the changes persist long-term. Your doctor will track your heart function on a set schedule to catch any changes early, when they’re most treatable.
What Changes After Treatment Ends
Once you receive your final Phesgo dose, the trajectory of side effects depends on whether you were also receiving chemotherapy. If chemotherapy ends at the same time or has already finished, many patients notice a significant improvement in nausea, fatigue, and diarrhea within the first month or two. If Phesgo was your only remaining treatment (as in the maintenance phase for early breast cancer), the transition is often smoother because your body has already adjusted to the regimen.
The side effects with the longest tail are cardiac changes and general fatigue. Some patients report lingering tiredness for several months after their last dose, which aligns with the extended time these large antibody molecules take to clear the body. As the drug levels gradually drop over those three to four months, most residual symptoms taper off in parallel.